[Expression of IL-21 in the peripheral blood of myasthenia gravis patients and its correlation with anti-AChR-Ab class switch]
- PMID: 20871161
- DOI: 10.3969/j.issn.1672-7347.2010.09.010
[Expression of IL-21 in the peripheral blood of myasthenia gravis patients and its correlation with anti-AChR-Ab class switch]
Abstract
Objective: To explore the role of IL-21 in the pathogenesis of myasthenia gravis (MG) and its influence on the the class switch of anti-AChR antibodies.
Methods: Blood was taken from 26 patients and 18 healthy controls, and the expression of IL-21R mRNA in peripheral blood mononuclear cells (PBMCs) was detected by RT-PCR. The expression of IL-21R on B lymphocytes was measured by flow cytometry, while the concentrations of serum IL-21 and the levels of anti-AChR-IgG and its isotype IgG(1), IgG(2), and IgG(3) were tested by ELISA.
Results: The serum concentration of IL-21 in the MG group was higher than that in the control group (31.686±8.499 pg/mL, 15.147±6.366 pg/mL) and the difference was significant (P<0.01). IL-21R mRNA expressed on PBMCs in the MG group was higher than that in the control group (0.139±0.052, 0.101±0.022), and the difference was significant (P<0.05). There was no difference between ocular MG and generalized MG subgroup (P>0.05). Compared with the control group, the expression of IL-21R on B lymphocytes also increased in the MG group (P<0.05). In the anti-AChR-Ab positive MG group, the serum concentration of IL-21 showed positive correlation with anti-AChR-IgG(P<0.05),but no correlation with its isotype IgG(1), IgG(2), and IgG(3), respectively(P>0.05). Expression of IL-21R mRNA in the PBMCs showed no correlation with the level of serum anti-AChR-IgG and its isotype IgG(1), IgG(2), and IgG(3), respectively(P>0.05); however the expression of IL-21R in B lymphocytes showed positive correlation with anti-AChR-IgG and it's isotype IgG(1) and IgG(3) (P<0.05,P<0.01,P<0.05), but no correlation with IgG(2) (P>0.05).
Conclusion: IL-21 might induce the class switch of anti-AChR antibodies to IgG(1) and IgG(3) isotype through IL-21R on B lymphocytes which promotes the pathogenesis of the MG.
Similar articles
-
Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis.Neurol Sci. 2014 Jan;35(1):29-34. doi: 10.1007/s10072-013-1460-3. Epub 2013 May 26. Neurol Sci. 2014. PMID: 23708911
-
Expression of interleukin-22 in myasthenia gravis.Scand J Immunol. 2013 Jul;78(1):98-107. doi: 10.1111/sji.12057. Scand J Immunol. 2013. PMID: 23617779
-
Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis.J Immunol. 2001 Apr 15;166(8):4853-62. doi: 10.4049/jimmunol.166.8.4853. J Immunol. 2001. PMID: 11290761
-
[Antibodies in myasthenia gravis].Rev Neurol (Paris). 2009 Feb;165(2):137-43. doi: 10.1016/j.neurol.2008.11.020. Epub 2009 Jan 21. Rev Neurol (Paris). 2009. PMID: 19162288 Review. French.
-
Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.Autoimmunity. 2010 Aug;43(5-6):353-70. doi: 10.3109/08916930903555943. Autoimmunity. 2010. PMID: 20380584 Review.
Cited by
-
Interleukin-27 levels in patients with myasthenia gravis.Transl Neurosci. 2020 Sep 9;11(1):302-308. doi: 10.1515/tnsci-2020-0134. eCollection 2020. Transl Neurosci. 2020. PMID: 33312724 Free PMC article.
-
Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis.Neurol Sci. 2014 Jan;35(1):29-34. doi: 10.1007/s10072-013-1460-3. Epub 2013 May 26. Neurol Sci. 2014. PMID: 23708911
-
[Roles of interleukin-21 and its receptor in autoimmune diseases].Zhongguo Dang Dai Er Ke Za Zhi. 2016 May;18(5):466-71. doi: 10.7499/j.issn.1008-8830.2016.05.017. Zhongguo Dang Dai Er Ke Za Zhi. 2016. PMID: 27165599 Free PMC article. Review. Chinese.
-
Central Role of T Follicular Helper Cells in Myasthenia Gravis.Noro Psikiyatr Ars. 2021 Jan 16;58(1):68-72. doi: 10.29399/npa.27193. eCollection 2021 Mar. Noro Psikiyatr Ars. 2021. PMID: 33795956 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical